Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.22.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Net revenue:      
Total revenue, net $ 45,605 $ 50,118 $ 318
Operating expenses:      
Cost of sales 1,091 0 0
Selling, general and administrative 171,438 95,983 22,338
Research and development 51,139 50,327 52,866
Amortization of intangible assets 2,098 1,289 1,138
Other expense, net 574 6,809 14,919
Total cost of sales and operating expenses 226,340 154,408 91,261
Loss from operations (180,735) (104,290) (90,943)
Interest income 529 1,516 2,702
Net loss before income taxes (180,206) (102,774) (88,241)
Income tax expense (benefit) 760 (94) 144
Net loss (180,966) (102,680) (88,385)
Other comprehensive loss:      
Unrealized (loss) gain on available-for-sale securities, net of tax of nil (47) 0 0
Comprehensive loss $ (181,013) $ (102,680) $ (88,385)
Basic loss per common share (in dollars per share) $ (1.40) $ (0.87) $ (0.95)
Diluted loss per common share (in dollars per share) $ (1.40) $ (0.87) $ (0.95)
Weighted-average common shares outstanding used in computation of basic and diluted loss per share (in dollars per share) 129,369,000 118,473,000 93,024,000
Product revenue, net      
Net revenue:      
Total revenue, net $ 45,488 $ 0 $ 0
License and contract revenue      
Net revenue:      
Total revenue, net $ 117 $ 50,118 $ 318